Drug
Interleukin 4 Pe38kdel Cytotoxin
Interleukin 4 Pe38kdel Cytotoxin: highest development phase Phase 2, developed by Neurocrine Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Neurocrine Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| interleukin-4 PE38KDEL cytotoxin NCT00014677 | Phase 2 | Brain and Central Nervous System Tumors |
Latest
No recent events.
Follow Interleukin 4 Pe38kdel Cytotoxin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.